157 related articles for article (PubMed ID: 15032392)
1. Pyridoxine-dependent seizures: magnetic resonance spectroscopy findings.
Alkan A; Kutlu R; Aslan M; Sigirci A; Orkan I; Yakinci C
J Child Neurol; 2004 Jan; 19(1):75-8. PubMed ID: 15032392
[TBL] [Abstract][Full Text] [Related]
2. A 9-year follow-up of a girl with pyridoxine (vitamin B6)-dependent seizures: magnetic resonance spectroscopy findings.
Dogan M; Dogan DG; Kahraman AS; Ozcan O; Yakinci C; Alkan A
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):695-8. PubMed ID: 22774414
[TBL] [Abstract][Full Text] [Related]
3. Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy.
Simister RJ; McLean MA; Barker GJ; Duncan JS
Neurology; 2003 Oct; 61(7):897-902. PubMed ID: 14557556
[TBL] [Abstract][Full Text] [Related]
4. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
Garcia M; Huppertz HJ; Ziyeh S; Buechert M; Schumacher M; Mader I
Epilepsia; 2009 Mar; 50(3):486-92. PubMed ID: 19183221
[TBL] [Abstract][Full Text] [Related]
5. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.
Sanacora G; Gueorguieva R; Epperson CN; Wu YT; Appel M; Rothman DL; Krystal JH; Mason GF
Arch Gen Psychiatry; 2004 Jul; 61(7):705-13. PubMed ID: 15237082
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents.
Davanzo P; Yue K; Thomas MA; Belin T; Mintz J; Venkatraman TN; Santoro E; Barnett S; McCracken J
Am J Psychiatry; 2003 Aug; 160(8):1442-52. PubMed ID: 12900307
[TBL] [Abstract][Full Text] [Related]
7. Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study.
Nilsen LH; Melø TM; Saether O; Witter MP; Sonnewald U
J Neurochem; 2012 Nov; 123(4):532-41. PubMed ID: 22943908
[TBL] [Abstract][Full Text] [Related]
8. Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain.
Petroff OA; Pleban LA; Spencer DD
Magn Reson Imaging; 1995; 13(8):1197-211. PubMed ID: 8750337
[TBL] [Abstract][Full Text] [Related]
9. [Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
Pozdniakov AV; Tiutin LA; Bisaga GN; Odinak MM
Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(4):36-9. PubMed ID: 11490432
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C disease.
Tedeschi G; Bonavita S; Barton NW; Betolino A; Frank JA; Patronas NJ; Alger JR; Schiffmann R
J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):72-9. PubMed ID: 9667565
[TBL] [Abstract][Full Text] [Related]
11. Brain magnetic resonance spectroscopy in Tourette's disorder.
DeVito TJ; Drost DJ; Pavlosky W; Neufeld RW; Rajakumar N; McKinlay BD; Williamson PC; Nicolson R
J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1301-8. PubMed ID: 16292123
[TBL] [Abstract][Full Text] [Related]
12. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis.
Yildiz-Yesiloglu A; Ankerst DP
Psychiatry Res; 2006 Jun; 147(1):1-25. PubMed ID: 16806850
[TBL] [Abstract][Full Text] [Related]
13. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
14. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A
Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051
[TBL] [Abstract][Full Text] [Related]
15. Proton MR spectroscopy of brain abnormalities in neonates born to HIV-positive mothers.
Cortey A; Jarvik JG; Lenkinski RE; Grossman RI; Frank I; Delivoria-Papadopoulos M
AJNR Am J Neuroradiol; 1994 Nov; 15(10):1853-9. PubMed ID: 7863935
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
Baruth JM; Wall CA; Patterson MC; Port JD
Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
18. A proton magnetic resonance spectroscopy study of metabolites in the occipital lobes in epilepsy.
Simister RJ; McLean MA; Barker GJ; Duncan JS
Epilepsia; 2003 Apr; 44(4):550-8. PubMed ID: 12681004
[TBL] [Abstract][Full Text] [Related]
19. N-acetylaspartate and epilepsy.
Gadian DG
Magn Reson Imaging; 1995; 13(8):1193-5. PubMed ID: 8750336
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance spectroscopy findings in photosensitive idiopathic generalized epilepsy.
Aydin-Ozemir Z; Terzibasioglu E; Altindag E; Sencer S; Baykan B
Clin EEG Neurosci; 2010 Jan; 41(1):42-9. PubMed ID: 20307015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
